YEAR: 2006
Major Depressive Disorder: Clinical Challenges, Therapeutic Solutions?
European Regional Medical Conference organised by The Lilly/Boehringer Ingelheim Alliance
31 March – 1 April , 2006, Geneva, Switzerland
International Neuroscience Conference 2006
April 28th – 29th, 2006, Paris, France
Schizophrenia: future perspectives and insights in day to day treatment
Educational symposium organised by Janssen-Cilag
April 28th – 29th, 2006, Brussels, Belgium
XIV World Congress on Psychiatric Genetics
October 28th-November 1st 2006, Cagliari
Broadening horizons in psychiatric illness
Circuitry, pharmacology and synergies workshop
Organised by AstraZeneca
27 March 2006, Barcelona, Spain
Broadening horizons in psychiatric illness
Meeting organised by AstraZeneca
27-29 March 2006, Barcelona, Spain
‘Addressing Unmet Needs in the Long-Term Treatment of Bipolar Disorder ’Satellite symposium supported by an unrestricted educational grant from Eli Lilly and Company at the 19th ECNP Congress
20 September,2006, Paris
‘Challenges in Major Depressive Disorder: Managing Common Comorbid Problems and Treating the « Whole » Patient - ’
Satellite symposium supported by an unrestricted educational grant from Wyeth at the 19th ECNP Congress
20 September,2006, Paris
‘New developments of lithium and valporate in the treatment of mania’
Satellite symposium supported by an unrestricted educational grant from Sanofi-Aventis 19th ECNP Congress
19 September,2006, Paris
‘Negative Symptoms and Schizophrenia: Recognition, Measurement and Treatment’
Satellite symposium supported by an unrestricted educational grant from Pfizer/Organon at the 19th ECNP Congress
19 September,2006, Paris
« The melatonergic approach in depression: from pharmacology to clinical evidence »
Satellite symposium supported by an unrestricted educational grant from Servier at the 19th ECNP Congress
19 September,2006, Paris
«Obsessive spectrum disorders over the life cycle»Satellite symposium supported by an unrestricted educational grant from Lundbeck at the 19thECNP Congress
19 September,2006, Paris
‘From acute to long-term: Effectiveness is a moving target’
Satellite symposium supported by an unrestricted
Educational grant from Brystol-Myers Squibb and Otsuka at the 19th ECNP Congress
18 September,2006, Paris
« Schizophrenia, patients, physicians:
a collaborative approach to treatment»
Closed meeting supported by an unrestricted educational grant from AstraZeneca
18 September,2006, Paris
« New perspectives on efficacy in the treatment of schizophrenia »
Satellite symposium supported by an unrestricted educational grant from Janssen at the 19th ECNP Congress
18 September,2006, Paris
« Taking Depression Treatment to the Next Level»
Satellite symposium supported by an unrestricted educational grant from Eli Lilly and Company at the 19th ECNP Congress
18 September,2006, Paris
‘New horizons in affective disorders: targets, translation
approaches and treatment opportunities’
Satellite symposium supported by an unrestricted
educational grant from Organon International at the 19th ECNP Congress
18 September,2006, Paris
«Bipolar disorder and beyond: a fresh
perspective for atypical antipsychotics»
Satellite symposium supported by an unrestricted educational grant from AstraZeneca at the 19th ECNP Congress
17 September,2006, Paris
Generalised Anxiety Disorder: Strategies for Optimising Treatment Response
Satellite symposium supported by an unrestricted educational grant from Pfizer Inc. on the occasion of the 19th ECNP Congress
17 September,2006, Paris
« Antidepressant pharmacology: from clinical trials
to clinical practice »
Satellite symposium supported by an unrestricted
Educational grant from GlaxoSmithKline at the 19th ECNP Congress
17 September,2006, Paris
‘Raising the Standard of Care to Improve Long-Term Outcomes in Schizophrenia’
Satellite symposium supported by an unrestricted educational grant from Eli Lilly and Company of the 19th ECNP Congress
17 September,2006, Paris
19th Congress of the European College of Neuropsychopharmacology
September 16-20, 2006, Paris
Synthesising Evidence Into Clinical Practice: Focus on the Long-term Management of Schizophrenia and Bipolar Disorder
Satellite symposium supported by an unrestricted educational grant from Pfizer Inc. on the occasion of the 19th ECNP Congress
16 September,2006, Paris
« Raising the bar for schizophrenia outcome with a long-acting formulation: the scientific facts »
Satellite symposium supported by an unrestricted educational grant from Janssen at the 19th ECNP Congress
16 September,2006, Paris
« ADHD Grows Up: Recognition and Treatment of Adults »
Satellite symposium supported by an unrestricted educational grant from Eli Lilly and Company at the 19th ECNP Congress
16 September,2006, Paris
« Content versus delivery:
challenges and options in the treatment of schizophrenia»
Satellite symposium supported by an unrestricted
educational grant from Lundbeck at the 19th ECNP Congress
16 September,2006, Paris
‘Depression and chronic pain: physical or psychological’
Satellite symposium supported by an unrestricted educational grant from Pierre Fabre at the 19th ECNP Congress
16 September,2006, Paris
‘Anxiety and depression: managing Co-conspirators for chronicity – a case based Discussion Forum’
Satellite symposium supported by an unrestricted educational grant from Wyeth at the 19th ECNP Congress
16 September,2006, Paris
«Schizophreniaand Bipolar Disorders:The Contribution of Olanzapine to a Decade of Therapeutic Progress»Stand alone meeting sponsored by Eli Lilly and Company
15 September,2006, Paris
8th Congress of the European Society for Clinical NeuroPharmacology
Organised by VU University Medical Center
June 14th, 2006, Amsterdam
5th International Congress on Mental Dysfunction in Parkinson’s Disease
Organised by VU University Medical Center
June 12-14, 2006, Amsterdam
The journey from diagnosis to recovery: a patient-psychiatrist partnership
Meet the expert workshops
Meeting organised by AstraZeneca
11-13 October 2006 , Lisbon, Portugal
The journey from diagnosis to recovery:a patient-psychiatrist partnership
Meeting organised by AstraZeneca
Lisbon, Portugal, 11-13 October 2006
11-13 October 2006 , Lisbon, Portugal
Mind Matters
7th International Psychiatry Forum
Organised by Sanofi-Aventis
June 9-11, 2006, Dublin, Ireland
Evidence-based Medicine in Mood Disorders
Lundbeck Institute Workshop (Asia)
June 8-10, 2006, Bangkok
ADHD in Europe: Current knowledge and future directions
educational symposium supported by Janssen-Pharmaceutica
December 7th – 9th, 2006, Barcelona
4th UCB Global Epilepsy Summit
7-8th October, 2006, Prague
4th UCB Global Epilepsy Summit
7-8 October, 2006, Prague
‘ADHD in Europe: Current knowledge and future directions’
educational symposium supported by Janssen-Pharmaceutica
December 7th – 9th, 2006, Barcelona
‘ADHD in Europe: Current knowledge and future directions’
educational symposium supported by Janssen-Pharmaceutica
December 7th – 9th, 2006, Barcelona
Bipolar disorder: treatment approaches for a multidimensional disease
Satellite symposium of ISBD sponsored by AstraZeneca
3rd August 2006, Edinburgh
Towards DSM V: Revision or Improvement? Everything you want to know
Conference supported by Organon
June 2nd, 2006, Brussels
“Major Depressive Disorder: Clinical Challenges, Therapeutic Solutions ?”
An educational symposium supported by Eli Lilly and Company & Boehringer Ingelheim
1–2 December, 2006, Prague
“Major Depressive Disorder: Clinical Challenges, Therapeutic Solutions ?”
An educational symposium supported by Eli Lilly and Company & Boehringer Ingelheim
1–2 December, 2006, Prague
Major Depressive Disorder: Clinical Challenges, Therapeutic Solutions ?
An educational symposium supported by Eli Lilly and Company & Boehringer Ingelheim
1–2 December, 2006, Prague
“Major Depressive Disorder: Clinical Challenges, Therapeutic Solutions ?”
An educational symposium supported by Eli Lilly and Company & Boehringer Ingelheim
1–2 December, 2006, Prague